loader2
Partner With Us NRI

Pfizer Ltd share Price Today

Company details

4,468.00
4,584.95
3,720.00
5,000.00
6M Return 11.77%
1Y Return 19.16%
Mkt Cap.(Cr) 20,822.66
Volume 18,901
Div Yield 0.77%
OI
-
OI Chg %
-
Volume 18,901

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500
About The Stock

    Pfizer collectively addresses 15 therapy areas in the domestic formulations with a portfolio of over 150 products that include therapeutics & vaccines. The company has been continuously restructuring its portfolio in the last few years to improve the productivity of its core brands.

    • Fourth largest multinational pharma company in India with manufacturing facility in Goa with a run rate of 3.36 billion tablets per annum
    • Top Therapies: VMN, anti-infective, cardiac, gastro and respiratory; Top Brands: Prevenar 13, Becosules, Corex-Dx, Dolonex and Mucaine
Q1FY23

    Revenue growth was subdued this quarter on a high base of Q1FY22 while numbers have picked up sequentially.

    • Sales declined 21% YoY to ₹ 593 crore (up 8% QoQ)
    • EBITDA de-grew 33% YoY to ₹ 192 crore (up 16% QoQ), while EBITDA margins declined by 578 bps YoY to 32.4% (up 226 bps QoQ)
    • PAT for the quarter was down 15% YoY to ₹ 169 crore (up 34% QoQ)

Click here for full recommendation

Research view on more stocks

Pfizer Ltd shares SWOT Analysis

Strengths (7)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Growth in Net Profit with increasing Profit Margin (QoQ)
  • Company with Low Debt

Weakness (5)

  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Inefficient use of shareholder funds - ROE declining in the last 2 years
  • Inefficient use of assets to generate profits - ROA declining in the last 2 years

Opportunity (2)

  • Negative to Positive growth in Sales and Profit with Strong Price momentum
  • RSI indicating price strength

Threats (1)

  • Increasing Trend in Non-Core Income

Resistance and support

R1 4,601.7
R2 4,651.8
R3 4,718.7
Pivot

4,534.85

S1 4,484.8
S2 4,417.9
S3 4,367.8
EMA SMA
4,385.9
4,338.1
4,301.6
4,220.1
4,356.0
4,293.9
4,365.7
4,167.1
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
Name Category Shares
PFIZER EAST INDIA B V PROMOTER 39.75%
WYETH LLC PROMOTER 12.28%
WYETH HOLDINGS CORPORATION PROMOTER 3.56%
WARNER-LAMBERT COMPANY LLC PROMOTER 2.6%
PARKE, DAVIS & COMPANY LLC PROMOTER 2.09%
JOHN WYETH & BROTHER LTD PROMOTER 1.93%
PHARMACIA CORPORATION PROMOTER 1.71%

OUR RESEARCH VIEW

Investment recommendation
Call Date
06 Aug 2022
Entry Price 4,191.00
Target Price 4,480.00
Duration
12-18 Month

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Pfizer Ltd Stocks COMPARISON

Financials( in Cr) Pfizer Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Zydus Lifesciences Ltd
Price 4,551.60 1,466.05 1,478.65 4,255.25 1,058.50
% Change 1.07 -1.39 -0.52 3.22 -1.63
Mcap Cr 20,822.66 351,754.51 119,381.32 112,963.70 106,509.87
Revenue TTM Cr 2,424.76 43,885.68 15,790.60 7,767.51 17,237.40
Net Profit TTM Cr 623.93 8,560.84 2,513.47 1,823.38 1,997.30
PE TTM 38.19 35.16 28.03 70.58 27.63
1 Year Return 19.16 53.97 57.64 25.78 110.04
ROCE 25.88 16.79 14.76 19.30 16.25
ROE 20.55 16.46 10.66 14.89 14.05
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 3,207.30 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 35,090.66 -22,978.04
LAST 3M 106,793.94 -34,010.07
LAST 6M 169,541.16 45,373.47
LAST 12M 268,709.66 125,819.23

Pfizer Ltd Information

Stock PE (TTM)
38.19
Promoter Holding
63.92%
Book Value
785.9488
ROCE
25.88%
ROE
20.55%
Description
  • Pfizer Ltd is in the Pharmaceuticals sector, having the Market Capitalization of worth Rs. 26,896.85 crores, it is incorporated in the year 1986. It has reported consolidated sales of Rs. 749.17 crores in June’2021. The company is listed in the Bombay Stock Exchange (BSE) with the code 500680, and also listed in the National Stock Exchange (NSE) with the code PFIZER.

    Pfizer Ltd is the fourth largest multinational pharmaceuticals company in India. Pfizer ltd is a subsidiary of Pfizer Inc. It holds 40% ownership of Pfizer Ltd. Pfizer Ltd is also known for its award-winning manufacturing facility having state-of-the-art technology and the capacity to produce over one billion tablets annually. Some of the many top brands produced by Pfizer are Prevenar 13, Dolonex, Corex, Becosules, Gelusil, etc. Pfizer ltd enjoys a unique advantage as it gets access to Pfizer Inc’s global portfolio of therapies and introduces them into Indian markets. Pfizer ltd is also the first pharmaceutical company to start clinical research in the country. Although Pfizer ltd was incorporated in 1986, it had already entered the Indian markets in 1950 through Dumex ltd. The promoters of the company own 63.92% of the stake in the company, Foreign Institutional Investors (FII) own 1.95%, Domestic Institutional Investors (DII) own 14.96% of the stake, and others (such as public & retail
    investors) hold the balance of 19.17%.

    In June 2021, quarterly net revenue was Rs. 749.17 crores, which has increased by approximately 45.50 % from Rs. 380.28 crores for the April-June 2020 quarter. The quarterly net profit in June 2021 was Rs. 199.91 crores, which has also increased by nearly 60.63% from a net profit of Rs. 124.45 crores in June 2020. In June 2021, the reported operating profit was at Rs. 666.86 crores, which is also increased by 42.81% as compared to an operating profit of Rs. 466.96 crores for the quarter ending in June 2020. From Rs. 27.20 in June 2020, the EPS of Pfizer has risen to Rs. 43.69 per share in June 2021. PFIZER’s stock closed at Rs. 5879.35 on 18th August’2021 (NSE) and has returned 27.44% in the last six months and 29.38% in the previous year.

Registered Address

The Capital 1802/1901 Plot-C70, G Bl Bandra Kurla Cpx Bandra-E, Mumbai, Maharashtra, 400051

Tel : 91-22-66932000
Email : contactus.india:pfizer.com
Website : http://www.pfizerindia.com
Registrar

Karvy Computershare Pvt Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 500680
NSE Code : PFIZER
Book Closure Date (Month) :
BSE Group : A
ISIN : INE182A01018

FAQ’s on Pfizer Ltd Shares

You can buy Pfizer Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Pfizer Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of May 27, 2024 03:55 PM the closing price of Pfizer Ltd was Rs.4,551.60.

Market capitalization or market cap is determined by multiplying the current market price of a company�s shares with the total number of shares outstanding. As of May 27, 2024 03:55 PM, the market cap of Pfizer Ltd stood at Rs. 20,822.66.

The latest PE ratio of Pfizer Ltd as of May 27, 2024 03:55 PM is 38.19

The latest PB ratio of Pfizer Ltd as of May 27, 2024 03:55 PM is 0.17

The 52-week high of Pfizer Ltd share price is Rs. 5,000.00 while the 52-week low is Rs. 3,720.00

According to analyst recommendations, Pfizer Ltd Share has a "Buy" rating for the long term.

Download App

Download Our App

Play Store App Store
market app